Portfolio company
gMendel
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI-powered software and diagnostic tests for prenatal and newborn genetic disorder screening for hospitals, laboratories and health ministries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Diagnoly
This company develops artificial intelligence software for prenatal ultrasound imaging to help healthcare professionals detect fetal abnormalities.
Mendel
The company develops artificial intelligence software to structure and analyse clinical data for life sciences organisations and healthcare providers.
FDNA
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
MederiAI
This company develops AI software for healthcare professionals to analyse capsule endoscopy videos and identify gastrointestinal anomalies.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
Siloam Vision
This company develops AI-enabled retinal imaging systems and diagnostic software for healthcare providers to detect preventable blindness in neonates and adults.
BrightHeart
This company develops AI software for clinicians to improve the detection of congenital heart defects during routine prenatal ultrasound exams.
